Gastrointestinal oncology - near future reality?
EditorialGastroent Hepatol 2012; 66(5): 330.
pdf Štěpán SuchánekObčanské sdružení pacientů s idiopatickými střevními záněty - Pacienti IBD
NewsGastroent Hepatol 2012; 66(6): 489-490.
pdf Martina PfeiferováDoes golimumab extend the spectrum of anti-TNFα inhibitors for inflammatory bowel diseases?
Review articleGastroent Hepatol 2012; 66(6): 465-469.
Summarypdf Milan LukášChanges in body weight and eating habits of obese patients after sleeve gastrectomy - a pilot study
Original articleGastroent Hepatol 2012; 66(6): 444-449.
Summarypdf Vladislava Zavadilová, Marek Bužga, Adéla Chroboková, Roman Végh, Pavol HoléczyEURO-NOTES 2012, 4.–6. October 2012, Prague
Congress reportsGastroent Hepatol 2012; 66(6): 431.
pdf Jan MartínekSerum zymogen glycoprotein 2 antibodies (anti-GP2) in patients with inflammatory bowel disease
Original articleGastroent Hepatol 2013; 67(1): 10-16.
Summarypdf Karin Malíčková, Dana Ďuricová, Martin Bortlík, Luděk Hrdlička, Naděžda Machková, Milan LukášAminosalicyláty v liečbe aktívnej Crohnovej choroby - kedy a prečo nie
NewsGastroent Hepatol 2013; 67(1): 69-70.
pdf Zuzana ZelinkováStents in treatment of colorectal cancer - summary and personal experience
Review articleGastroent Hepatol 2013; 67(1): 49-53.
Summarypdf Ľuboš Žitňan, Juraj Májek, Boris Pekárek, Peter Makovník18FDG-PET/CT diagnostics of pancreatic adenocarcinoma
Review articleGastroent Hepatol 2013; 67(1): 45-48.
Summarypdf Pavel FenclAcute gastrointestinal bleeding and changes in lipid profile - pilot project
Review articleGastroent Hepatol 2013; 67(1): 30-36.
Summarypdf Vladimír Hrabovský, Alice Mendlová, Zdeněk Zadák, Vladimír Bláha, Radomír Hyšpler, Alena Tichá, Zdeněk Švagera